News

New research shows that people nursing homes with higher concentrations of Black and Latino residents were more than 50% more likely to be infected with COVID and twice as likely to die in the first ...

Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer’s disease – making it the first new drug in nearly 20-years to treat the ...

URMC is participating in a new clinical trial that will help inform public health decisions around re-vaccination schedules and the deployment of boosters that target COVID variants.

Tell your health care providers the date of your vaccine and what arm received the shot - especially if you have an imaging scan coming up.

Jodi Lown has always dreamt of going to France. She had no idea a lymphoma diagnosis would bring France to her, in the form of a stem cell transplant, or that she would find a way to return an active ...

Wilmot patients benefit from major improvements in treating gastrointestinal tumors - the "Advance of the Year" in oncology.

New research suggests that targeted leukemia treatment may be able to correct the faulty genes that fuel cancer at its root.

There’s a misconception that, when a cancer patient is offered a clinical trial, the end is near. But multiple myeloma survivor Alan Brandon is living proof dispelling that notion.

Wastewater monitoring is a promising tool for COVID-19 surveillance, according to a new paper published in the International Journal of Environmental Public Health. Researchers from the University of ...

By all accounts, COVID vaccines in use in the U.S. today are highly effective, but pregnant people have largely been left out of the research behind the vaccines. A new study at URMC will follow 135 ...